LivaNova PLC (NASDAQ:LIVN) Director Hugh M. Morrison sold 3,215 shares of the company’s stock in a transaction dated Friday, May 5th. The shares were sold at an average price of $55.89, for a total value of $179,686.35. Following the completion of the sale, the director now directly owns 2,000 shares of the company’s stock, valued at $111,780. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.
LivaNova PLC (NASDAQ:LIVN) traded up 1.31% on Friday, reaching $58.79. The company’s stock had a trading volume of 398,009 shares. The firm’s market cap is $2.87 billion. The firm has a 50 day moving average of $53.48 and a 200 day moving average of $48.76. LivaNova PLC has a 12 month low of $40.83 and a 12 month high of $63.21.
LivaNova PLC (NASDAQ:LIVN) last released its quarterly earnings results on Wednesday, May 3rd. The company reported $0.71 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.68 by $0.03. The firm had revenue of $285.10 million for the quarter. LivaNova PLC had a positive return on equity of 4.42% and a negative net margin of 5.51%. Analysts anticipate that LivaNova PLC will post $3.21 earnings per share for the current year.
A number of analysts recently issued reports on the company. Canaccord Genuity reissued a “hold” rating and set a $54.00 target price on shares of LivaNova PLC in a research note on Monday, February 6th. BTIG Research reaffirmed a “hold” rating on shares of LivaNova PLC in a report on Friday, March 10th.
Several institutional investors have recently added to or reduced their stakes in the company. Meadow Creek Investment Management LLC increased its position in LivaNova PLC by 11.4% in the first quarter. Meadow Creek Investment Management LLC now owns 2,464 shares of the company’s stock worth $121,000 after buying an additional 252 shares during the period. Glen Harbor Capital Management LLC increased its position in LivaNova PLC by 11.4% in the first quarter. Glen Harbor Capital Management LLC now owns 2,992 shares of the company’s stock valued at $147,000 after buying an additional 306 shares during the period. Capstone Asset Management Co. bought a new position in LivaNova PLC during the first quarter valued at $233,000. Advantus Capital Management Inc increased its position in LivaNova PLC by 3.3% in the first quarter. Advantus Capital Management Inc now owns 5,551 shares of the company’s stock valued at $272,000 after buying an additional 176 shares during the period. Finally, OppenheimerFunds Inc. bought a new position in LivaNova PLC during the first quarter valued at $291,000. Hedge funds and other institutional investors own 66.11% of the company’s stock.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.